Journal
THROMBOSIS RESEARCH
Volume 126, Issue 1, Pages E41-E45Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.thromres.2010.02.012
Keywords
Pre-eclampsia; Tissue factor; Tissue factor pathway inhibitor; Pathological hypercoagulable state
Categories
Funding
- Health Technique Foundation of Society and Development Bureau, Pudong District, Shanghai, China [PW2005-04]
Ask authors/readers for more resources
Objective: To investigate the mechanism underlying the hypercoagulable state in severe pre-eclampsia. Methods: Plasma tissue factor (TF) and tissue factor pathway inhibitor (TFPI) expression from pre-eclampsia patients and healthy pregnant controls were determined by ELISA. Placental TF and TFPI gene and protein expression were detected by quantitative RT-PCR, immunohistochemistry, and Western analysis. Results: The plasma TF level in the pre-eclampsia group was significantly higher than the control group (p<0.01), and surprisingly, the plasma TFPI-1 and TFPI-2 in the pre-eclampsia group were significantly lower (p<0.01). Placental TF gene and protein expression levels in the pre-eclampsia group was significantly higher than the control group, while TFPI-1 and TFPI-2 levels were significantly lower (p<0.05). Lastly, a significant correlation was found between plasma and placental TF protein levels in the pre-eclampsia group (p<0.01). Conclusion: Higher expression and/or release of TF from the placenta may contribute towards a pathological hypercoagulable state in pre-eclampsia patients. (C) 2010 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available